The biotech space is hot right now. And it’s likely to continue that way for some time. This is a rich space where investors can find market-beating potential far beyond the more traditional names that tend to dominate Wall Street. The best biotechnology stocks come in a variety of shapes and sizes. Some may focus on treating an individual disease; some may have many. Some are penny stock startup companies; others are dividend stocks. Most trade on the Nasdaq, but a few are considered blue chips and trade on the NYSE. Many are owned by institutional investors, but some of the top performers...

Investors looking for the next “big thing” in investing are likely to find what they want by seeking out small cap stocks. Small caps are a somewhat flexible term, but any company with a market capitalization under $1 billion is definitely one.  In today’s world, with some companies having trillion-dollar-plus valuations, even $10 billion could be considered small, although after that, you start to get into the mid cap category. Some are growth stocks with a high earnings yield, others are value stocks as determined by fundamental analysis. And not all small caps are penny stocks, as many s...